wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26775254-0A9798A7-CED8-4B0D-9508-B620262C3735
Q26775254-0A9798A7-CED8-4B0D-9508-B620262C3735
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775254-0A9798A7-CED8-4B0D-9508-B620262C3735
Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment
P2860
Q26775254-0A9798A7-CED8-4B0D-9508-B620262C3735
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26775254-0A9798A7-CED8-4B0D-9508-B620262C3735
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
603dc13c44e36e6c6e61bfdbc20af6214619c714
P2860
Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile.